Abstract
Paclitaxel has been proven to be effective against different types of cancer. A delivery system loaded with paclitaxel at tumor site should provide a high local concentration of the drug detrimental to malignant cells, which prevents the re-growth and metastasis of tumor. In this review, paclitaxel formulations for systemic and for intratumoral administration are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 397-402 |
| Number of pages | 6 |
| Journal | Current Medicinal Chemistry |
| Volume | 11 |
| Issue number | 4 |
| DOIs | |
| State | Published - Feb 2004 |
Keywords
- Delivery systems
- Formulations
- Intratumoral delivery
- Paclitaxel
- Polymers